Skip to content
AnalystLens

CME GROUP INC. 8-K Report, Financial Results (Oct 26, 2022)

Reports
Earnings & Results·Exhibits & Filings
Filing Date
Filed October 26, 2022
Period End
October 26, 2022
Security
CME
In the record · 2016–202610-K1110-Q328-K119

CME filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 119 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Nov ’17Nov ’17
  2. Leadership change8-K · Nov ’19Nov ’19
  3. Material agreement8-K · Nov ’21Nov ’21
  4. Leadership change8-K · Sep ’26Sep ’26

Summary

Summary of the 8-K filed October 26, 2022. Cited figures are marked; the original filing is the authoritative source.

CME Group Inc. (CME) filed an 8-K on October 26, 2022, to report its financial results for the quarter ended September 30, 2022.

The filing primarily consists of a press release that details the company's earnings, including both GAAP and non-GAAP financial measures. Investors should note that the press release provides supplemental non-GAAP net income and earnings per share, which management believes offer a better view of financial and business trends and comparability with prior periods. The company emphasizes that these non-GAAP measures are supplementary and should not be considered a substitute for GAAP figures.

A reconciliation between the non-GAAP and GAAP financial measures is included in the press release, as required by Regulation G. This 8-K serves as the official notification of these results, with the press release attached as Exhibit 99.1.

Key Highlights

  1. CME Group Inc. reported its Q3 2022 financial results on October 26, 2022, via an 8-K filing.
  2. The filing includes a press release (Exhibit 99.1) detailing the financial performance for the quarter ended September 30, 2022.
  3. The press release presents both GAAP and non-GAAP financial measures for net income and earnings per share.
  4. Management utilizes non-GAAP figures to provide supplemental information on financial and business trends.
  5. Non-GAAP measures are intended to enhance comparability with prior financial periods.
  6. Reconciliation between non-GAAP and GAAP financial measures is provided, adhering to Regulation G requirements.
  7. The information in the press release is furnished and not deemed "filed" under Section 18 of the Securities Exchange Act of 1934.

Frequently Asked Questions

  1. What is the main purpose of this 8-K filing by CME Group?

    The main purpose of this 8-K filing is to officially report CME Group Inc.'s financial results for the third quarter ended September 30, 2022. It incorporates a press release that contains the detailed financial information.

  2. What are non-GAAP financial measures, and why are they included?

    Non-GAAP financial measures, such as non-GAAP net income and earnings per share, are financial metrics that exclude or adjust for certain items from the corresponding GAAP (Generally Accepted Accounting Principles) measures. CME Group includes them because management believes they provide important supplemental information about financial and business trends and improve comparability with the company's prior financial reports.

  3. Should investors rely solely on the non-GAAP financial measures presented?

    No, investors should not rely solely on the non-GAAP financial measures. CME Group explicitly states that these non-GAAP measures should be considered a supplement to, and not a substitute for, or superior to, the corresponding measures calculated in accordance with GAAP. A reconciliation to GAAP figures is provided for completeness.

  4. Where can I find the detailed financial results?

    The detailed financial results, including both GAAP and non-GAAP figures and their reconciliation, are located within the press release attached as Exhibit 99.1 to this 8-K filing.